Chien Kang Biotechnology will participate in the 2023 Taiwan International Medical and Healthcare Exhibition from June 8th to 10th (Booth Number: Q0330) at Nangang World Trade Center Hall 2, organized by the Taipei Medical Devices Commercial Association. They will showcase their latest products and technological innovations.
Chen Kang Biotechnology is a biotechnology company dedicated to integrating capabilities and resources, making its mark by leading the healthcare industry. By efficiently harnessing integrated capabilities, they effectively utilize resources in the medical field. Combining technology film processes with melt-blown non-woven fabric technology, they have successfully created low-resistance, dual-filter materials, achieving filtration efficiency of over 99% in masks, effectively protecting users from viruses and particulate matter.
At the same time, they have collaborated with the Wan Tai Group to establish a sterile production environment and have developed a series of antibacterial products. This includes silver-copper-titanium masks that offer over 99% bacteria and virus filtration, reducing the risk of cross-infection in the post-pandemic era. They have also introduced silver-copper-titanium antibacterial helmet pads, effectively reducing the risk of head infections for motorcycle riders, providing enhanced safety protection.
Utilizing ultra-fine fabric from the world's largest non-woven fabric manufacturer (imported from Europe), they have developed antibacterial cloths with outstanding bacteria removal capabilities, suitable for a wide range of applications in medical and home environments. Their anti-dust mite cotton effectively prevents dust mites from breeding, preventing allergy-related issues. The makeup removal cloth is made from soft and delicate materials, capable of gently removing makeup and impurities while being reusable, providing gentle care for the skin.
Chen Kang Biotechnology's products have undergone rigorous certifications and testing. Their N99 medical-grade respirator mask has been verified by the British and EU BSI certification agencies, demonstrating its outstanding filtration efficiency and safety in use. At the same time, their Type II medical-grade respirator mask is undergoing product certification and is expected to be available soon, providing consumers with a more comprehensive choice for protection. Chien Kang Biotechnology has also been recommended in an interview by the BSI Group, showcasing its quality and value.
